Drug Trial Radar · NCT00061750
Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
Last checked: Nov 19, 2026Latest source record: Apr 19, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
595
Actual
Start
May 2003
Primary completion
Nov 2004
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 4, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to deterimine if the new orally active iron chelator, ICL670, is as effective and as safe as deferoxamine in preventing accumulation of iron in the body while a patient is undergoing repeated blood transfusions.
Conditions
- Beta-Thalassemia
Interventions
ICL670Drug
deferoxamineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Demonstrate non-inferiority to deferoxamine in its effects on liver iron content (LIC)
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital of Los Angeles
Los Angeles, California
Children's Hospital Oakland
Oakland, California
Stanford Hospital
Stanford, California
Children's Memorial Hospital
Chicago, Illinois
Children's Hospital Boston
Boston, Massachusetts
Weill Medical College of Cornell University
New York, New York
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.